Neurological Surgery 脳神経外科43巻5号

2015年05月発行

--------------------

文献抄録　Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study):a multicentre, randomised, open-label, phase 3 trial／Patterns of progression in pediatric patients with high-grade glioma or diffuse intrinsic pontine glioma treated with bevacizumab-based therapy at diagnosis

著者： 黒住和彦¹

所属機関： ¹岡山大学脳神経外科

ページ範囲：P.481 - P.481